Slingshot members are tracking this event:
FDA Decision on Baricitinib Expected April 19 2017
Do you think this event is important to the companies below? How will it affect their stock price?
FDA was initially expected to make a decision in early Q4 of 2016, got delayed 3 months.
Slingshot Insights Explained
Apr 14, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Baricitinib, Fda Review, Nda Filing, Rheumatoid Arthritis